deltatrials
Completed NCT00086437

Pharmacogenetics of Hypertriglyceridemia in Hispanics

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Cardiovascular Diseases Heart Diseases Hypertriglyceridemia
Updated 10 times since 2017 Last updated: Dec 2, 2015 Started: Jul 31, 2004 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

A observational or N/A phase clinical study on Cardiovascular Diseases and Heart Diseases, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 10 data snapshots since 2004. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

▶ Show 5 earlier versions

  1. Jun 2018 — Nov 2020 [monthly]

    Completed

  2. May 2018 — Jun 2018 [monthly]

    Completed

  3. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  4. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  5. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
  • University of California, Los Angeles
Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.